Boehringer Ingelheim develops potential treatment for severe COVID-19 complications
The FINANCIAL -- Boehringer Ingelheim announced the initiation of a Phase 2 clinical trial of BI 764198, an inhibitor of ...
ADVERTISEMENT
Tag: cvodi19
CDC Halloween guidelines warn about high risk activities
The FINANCIAL -- As many people in the United States begin to plan for fall and winter holiday celebrations, CDC ...
ADVERTISEMENT
Popular Last 24h
-
Ampersand wins £22m five-year contract at London Zoo
-
Santos’ final statement in court, was a tearful attempt to express remorse while urging leniency
-
Threats to Georgia Amid Russia’s Advance in Ukraine and Trump’s Pro-Russia Policy
-
Armenia’s Post-War Economic Recovery: Resilience Amid Challenges
-
Soft2Bet is inviting talents to shape the future of iGaming
-
How Structured Interviewing Reduces Bias in Hiring
-
KPMG Data Products Survey Reveals Critical Insights on Data Product Success and Challenges
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
